Literature DB >> 22155780

Involvement of T6 pili in biofilm formation by serotype M6 Streptococcus pyogenes.

Keiji Richard Kimura1, Masanobu Nakata, Tomoko Sumitomo, Bernd Kreikemeyer, Andreas Podbielski, Yutaka Terao, Shigetada Kawabata.   

Abstract

The group A streptococcus (GAS) Streptococcus pyogenes is known to cause self-limiting purulent infections in humans. The role of GAS pili in host cell adhesion and biofilm formation is likely fundamental in early colonization. Pilus genes are found in the FCT (fibronectin-binding protein, collagen-binding protein, and trypsin-resistant antigen) genomic region, which has been classified into nine subtypes based on the diversity of gene content and nucleotide sequence. Several epidemiological studies have indicated that FCT type 1 strains, including serotype M6, produce large amounts of monospecies biofilm in vitro. We examined the direct involvement of pili in biofilm formation by serotype M6 clinical isolates. In the majority of tested strains, deletion of the tee6 gene encoding pilus shaft protein T6 compromised the ability to form biofilm on an abiotic surface. Deletion of the fctX and srtB genes, which encode pilus ancillary protein and class C pilus-associated sortase, respectively, also decreased biofilm formation by a representative strain. Unexpectedly, these mutant strains showed increased bacterial aggregation compared with that of the wild-type strain. When the entire FCT type 1 pilus region was ectopically expressed in serotype M1 strain SF370, biofilm formation was promoted and autoaggregation was inhibited. These findings indicate that assembled FCT type 1 pili contribute to biofilm formation and also function as attenuators of bacterial aggregation. Taken together, our results show the potential role of FCT type 1 pili in the pathogenesis of GAS infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155780      PMCID: PMC3272948          DOI: 10.1128/JB.06283-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  54 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes.

Authors:  Zerina Kratovac; Anand Manoharan; Feng Luo; Sergio Lizano; Debra E Bessen
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

Review 3.  Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria.

Authors:  Luciano A Marraffini; Andrea C Dedent; Olaf Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

4.  Pili of oral Streptococcus sanguinis bind to salivary amylase and promote the biofilm formation.

Authors:  Nobuo Okahashi; Masanobu Nakata; Yutaka Terao; Ryutaro Isoda; Atsuo Sakurai; Tomoko Sumitomo; Masaya Yamaguchi; Richard K Kimura; Eiji Oiki; Shigetada Kawabata; Takashi Ooshima
Journal:  Microb Pathog       Date:  2011-01-14       Impact factor: 3.738

5.  Streptolysin S contributes to group A streptococcal translocation across an epithelial barrier.

Authors:  Tomoko Sumitomo; Masanobu Nakata; Miharu Higashino; Yingji Jin; Yutaka Terao; Yukako Fujinaga; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

6.  Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci.

Authors:  O Schneewind; K F Jones; V A Fischetti
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

7.  The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes.

Authors:  G C Fogg; C M Gibson; M G Caparon
Journal:  Mol Microbiol       Date:  1994-02       Impact factor: 3.501

8.  Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain.

Authors:  David J Banks; Stephen F Porcella; Kent D Barbian; Stephen B Beres; Lauren E Philips; Jovanka M Voyich; Frank R DeLeo; Judith M Martin; Greg A Somerville; James M Musser
Journal:  J Infect Dis       Date:  2004-07-20       Impact factor: 5.226

9.  Transcriptome analyses extend understanding of Streptococcus pyogenes regulatory mechanisms and behavior toward immunomodulatory substances.

Authors:  Catur Riani; Kerstin Standar; Somboon Srimuang; Cordula Lembke; Bernd Kreikemeyer; Andreas Podbielski
Journal:  Int J Med Microbiol       Date:  2007-06-21       Impact factor: 3.473

10.  Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation.

Authors:  Sarah E Maddocks; Christopher J Wright; Angela H Nobbs; Jane L Brittan; Linda Franklin; Nicklas Strömberg; Aras Kadioglu; Mark A Jepson; Howard F Jenkinson
Journal:  Mol Microbiol       Date:  2011-07-15       Impact factor: 3.501

View more
  14 in total

Review 1.  Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains?

Authors:  Debra E Bessen
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

2.  Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.

Authors:  Tomas Fiedler; Catur Riani; Dirk Koczan; Kerstin Standar; Bernd Kreikemeyer; Andreas Podbielski
Journal:  Appl Environ Microbiol       Date:  2012-12-14       Impact factor: 4.792

3.  The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissue.

Authors:  Heaven Oliver-Kozup; Karen H Martin; Diane Schwegler-Berry; Brett J Green; Courtney Betts; Arti V Shinde; Livingston Van De Water; Slawomir Lukomski
Journal:  Mol Microbiol       Date:  2012-12-26       Impact factor: 3.501

4.  covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus.

Authors:  Ganapathy Ashwinkumar Subramenium; Dharmaprakash Viszwapriya; Prasanth Mani Iyer; Krishnaswamy Balamurugan; Shunmugiah Karutha Pandian
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 5.  Streptococcus pyogenes biofilms-formation, biology, and clinical relevance.

Authors:  Tomas Fiedler; Thomas Köller; Bernd Kreikemeyer
Journal:  Front Cell Infect Microbiol       Date:  2015-02-11       Impact factor: 5.293

6.  Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus emm32.2 Outbreak.

Authors:  Jennifer E Cornick; Anmol M Kiran; Roberto Vivancos; Jon Van Aartsen; Jenny Clarke; Edward Bevan; Mansoor Alsahag; Maaike Alaearts; Laura Bricio Moreno; Howard F Jenkinson; Angela H Nobbs; James Anson; Aras Kadioglu; Neil French; Dean B Everett
Journal:  J Clin Microbiol       Date:  2017-03-29       Impact factor: 5.948

7.  YvqE and CovRS of Group A Streptococcus Play a Pivotal Role in Viability and Phenotypic Adaptations to Multiple Environmental Stresses.

Authors:  Amonrattana Roobthaisong; Chihiro Aikawa; Takashi Nozawa; Fumito Maruyama; Ichiro Nakagawa
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

8.  Current Understanding of Group A Streptococcal Biofilms.

Authors:  Heema K N Vyas; Emma-Jayne Proctor; Jason McArthur; Jody Gorman; Martina Sanderson-Smith
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

Review 9.  Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes.

Authors:  Shigeyuki Hamada; Shigetada Kawabata; Ichiro Nakagawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

10.  Shin'iseihaito (Xinyiqingfeitang) Suppresses the Biofilm Formation of Streptococcus pneumoniae In Vitro.

Authors:  Masaaki Minami; Toru Konishi; Hiroshi Takase; Toshiaki Makino
Journal:  Biomed Res Int       Date:  2017-04-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.